ATE357854T1 - Prebiotische substanzen enthaltende ernährungszusammensetzungen - Google Patents

Prebiotische substanzen enthaltende ernährungszusammensetzungen

Info

Publication number
ATE357854T1
ATE357854T1 AT01910704T AT01910704T ATE357854T1 AT E357854 T1 ATE357854 T1 AT E357854T1 AT 01910704 T AT01910704 T AT 01910704T AT 01910704 T AT01910704 T AT 01910704T AT E357854 T1 ATE357854 T1 AT E357854T1
Authority
AT
Austria
Prior art keywords
compositions containing
nutritional compositions
prebiotic substances
containing prebiotic
substances
Prior art date
Application number
AT01910704T
Other languages
English (en)
Inventor
Jeffrey L Wilson
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24012783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357854(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE357854T1 publication Critical patent/ATE357854T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)
AT01910704T 2000-02-17 2001-02-15 Prebiotische substanzen enthaltende ernährungszusammensetzungen ATE357854T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50600900A 2000-02-17 2000-02-17

Publications (1)

Publication Number Publication Date
ATE357854T1 true ATE357854T1 (de) 2007-04-15

Family

ID=24012783

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01910704T ATE357854T1 (de) 2000-02-17 2001-02-15 Prebiotische substanzen enthaltende ernährungszusammensetzungen

Country Status (13)

Country Link
EP (1) EP1255449B2 (de)
JP (1) JP2003522784A (de)
CN (1) CN1229115C (de)
AR (1) AR027450A1 (de)
AT (1) ATE357854T1 (de)
AU (1) AU2001238285A1 (de)
BR (1) BRPI0108478B8 (de)
CA (1) CA2400737C (de)
DE (1) DE60127533D1 (de)
MX (1) MXPA02008016A (de)
PT (1) PT1255449E (de)
TW (1) TWI265008B (de)
WO (1) WO2001060346A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1243273A1 (de) * 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Zubereitung enthaltend einen praebiotischen Stoff für die Behandlung von Entzündungen und abnormale Aktivierung von nicht-spezifischen immunologischen Parametern
OA13142A (en) * 2002-10-11 2006-12-13 Wyeth Corp Nutritional formulations containing synbiotic substances.
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
US7867541B2 (en) * 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
DK1638418T3 (da) 2003-06-23 2012-09-17 Nestec Sa Aminosyretilsætning til et sundt mikrobiota-økosystem
ES2444843T3 (es) * 2003-09-18 2014-02-27 Arla Foods Amba Fórmula para lactantes
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
JPWO2007034748A1 (ja) * 2005-09-22 2009-03-26 株式会社林原生物化学研究所 腸管免疫調節剤
CA2628225C (en) * 2005-11-04 2014-06-17 Hans Henrik Holst A concentrate derived from a milk product enriched in naturally occurring sialyllactose and a process for preparation thereof
WO2009119315A1 (ja) * 2008-03-27 2009-10-01 森永乳業株式会社 酸性乳酸菌飲料および酸性乳酸菌飲料の製造方法
KR101116864B1 (ko) * 2008-08-01 2012-02-29 주식회사 베네비오 고지혈증, 지방간 또는 비만의 예방 또는 치료용 조성물
CA2984935C (en) 2009-02-24 2021-01-12 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
NL2004201C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
NL2004200C2 (en) * 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides in weight management.
WO2011136636A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
WO2011136647A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2658400A2 (de) 2010-12-31 2013-11-06 Abbott Laboratories Nahrungsformulierungen mit menschlichen milcholigosacchariden und antioxidantien und verwendungen davon
NZ611807A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
EP3338784B1 (de) 2010-12-31 2020-07-22 Abbott Laboratories Oligosaccharide aus muttermilch zur modulierung von entzündungen
BR112013016929A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas
MX356184B (es) * 2010-12-31 2018-05-17 Abbott Lab Fórmulación pediátrica sintética que comprende un probiótico.
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
MX388089B (es) 2010-12-31 2025-03-19 Abbott Lab Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
AU2012215042B2 (en) 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
PT2734049T (pt) 2011-06-20 2018-07-24 Heinz Co Brands H J Llc Composições e métodos probióticos
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
CN106659226A (zh) * 2014-08-18 2017-05-10 雀巢产品技术援助有限公司 用于降低以后生命中肥胖风险的益生元

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5953834B2 (ja) * 1982-05-19 1984-12-27 明治製菓株式会社 ビフイズス菌増殖促進物質
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
CN1121311A (zh) * 1993-02-26 1996-04-24 扬·施塔芬·诺马克 应用低聚糖苷作为细菌粘连的抑制剂
JPH07258093A (ja) * 1994-03-23 1995-10-09 Morinaga Milk Ind Co Ltd 神経成長因子様剤
JP3501415B2 (ja) * 1994-03-30 2004-03-02 雪印乳業株式会社 ビフィズス菌および乳酸菌増殖促進剤
CN1129524A (zh) * 1994-09-09 1996-08-28 哈尔滨松花江第二乳品厂 婴幼儿阶段奶粉
US5849324A (en) * 1995-07-10 1998-12-15 Abbott Laboratories Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
US5827526A (en) † 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
EP1094824B1 (de) * 1998-06-10 2006-04-05 Albert B. Crum Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
JP2002523025A (ja) * 1998-08-21 2002-07-30 アドヴァンスト・ニュートリショナル・フーズ・プロプライエタリー・リミテッド 組成物

Also Published As

Publication number Publication date
EP1255449B1 (de) 2007-03-28
DE60127533D1 (de) 2007-05-10
WO2001060346A3 (en) 2002-01-17
CN1406111A (zh) 2003-03-26
CA2400737A1 (en) 2001-08-23
PT1255449E (pt) 2007-08-24
AU2001238285A1 (en) 2001-08-27
CN1229115C (zh) 2005-11-30
EP1255449B2 (de) 2016-06-08
CA2400737C (en) 2010-12-14
TWI265008B (en) 2006-11-01
JP2003522784A (ja) 2003-07-29
WO2001060346A2 (en) 2001-08-23
AR027450A1 (es) 2003-03-26
BRPI0108478B1 (pt) 2017-05-30
MXPA02008016A (es) 2002-11-29
EP1255449A2 (de) 2002-11-13
BRPI0108478B8 (pt) 2021-05-25
BR0108478A (pt) 2003-04-22

Similar Documents

Publication Publication Date Title
DE60127533D1 (de) Prebiotische substanzen enthaltende ernährungszusammensetzungen
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
FI20105657L (fi) Farmaseuttisia koostumuksia
ATE303787T1 (de) Schergelzusammensetzungen
ITMI20010748A0 (it) Composizioni farmaceutiche
AR028197A1 (es) Composiciones antitranspirantes
ATE372372T1 (de) Zusammensetzungen enthaltend cyclodextrin
DK1575379T3 (da) Ernæringssammensætninger
EE05020B1 (et) Glburiidi ravimkoostis
DE60133928D1 (de) Schmelzbare sucralosezusammensetzung
DE60111212D1 (de) Flammhemmende polyesterzusammensetzungen
EE200300589A (et) Ravimkoostised
DE10196796T1 (de) Apatit-verstärkte Harz-Zusammensetzung
ATE369830T1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
ATE314049T1 (de) Schweisshemmende zusammensetzungen
FI20001153L (fi) Virtausta edistävä koostumus
DE60134551D1 (de) Harzzusammensetzung
DE60136220D1 (de) Flammhemmende polyesterzusammensetzungen
NO20031095D0 (no) Farmasöytiske sammensetninger
NO20032856D0 (no) Elektronisk tunge som ozon-detektor
DE60116858D1 (de) Zusammensetzung
DE60223762D1 (de) Zusammensetzung enthaltend Diätfasern
ATE369137T1 (de) Lyophilisierte formulierung enthaltend olanzapin
DE60115585D1 (de) Harzzusammensetzung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties